METASTATIC TRIPLE NEGATIVE BREAST CANCERS

Clinical trials for METASTATIC TRIPLE NEGATIVE BREAST CANCERS explained in plain language.

Never miss a new study

Get alerted when new METASTATIC TRIPLE NEGATIVE BREAST CANCERS trials appear

Sign up with your email to follow new studies for METASTATIC TRIPLE NEGATIVE BREAST CANCERS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1 Not yet finished but already full! 1

New hope for fighting breast cancer in the brain

Disease control Not yet recruiting

This study is testing an experimental drug called sacituzumab tirumotecan for people with a hard-to-treat type of breast cancer that has spread to the brain. The trial will enroll 20 participants to see if the drug can shrink or control the brain tumors and improve survival. The …

Matched conditions: METASTATIC TRIPLE NEGATIVE BREAST CANCERS

Phase: PHASE2 • Sponsor: Yale University • Aim: Disease control

Last updated Mar 16, 2026 15:27 UTC

METASTATIC TRIPLE NEGATIVE BREAST CANCERS

Get alerted when new METASTATIC TRIPLE NEGATIVE BREAST CANCERS trials appear

New hope for fighting breast cancer in the brain